This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ho, C. M. Articles by Hung, W. K. Search for Related Content PubMed PubMed Citation Articles by Ho, C. M. Articles by Hung, W. K. Related Collections Surgery

Skin Involvement in Invasive Breast Carcinoma: Safety of Skin-Sparing Mastectomy

From the Department of Surgery, Division of Plastic Surgery (CMH, WYC) and Breast Center (YL, MCMC, WKH), and the Department of Pathology (CKLM), Kwong Wah Hospital, Hong Kong SAR, China.

Correspondence: Address correspondence and reprint requests to: Chiu M. Ho, MS, Division of Plastic Surgery, Department of Surgery, Kwong Wah Hospital, Hong Kong SAR, China; Fax: 852-2781-5264; E-mail: hocm{at}ha.org.hk

Background: There is concern about the oncological safety of preserving most of the breast skin in skin-sparing mastectomy (SSM). Most supportive evidence for SSM evaluates the local recurrence rate on clinical follow-up.

Methods: The skin and 10 mm of the subcutaneous tissue of 30 total mastectomy specimens were studied with a step-serial sectioning technique. The incidence and mode of involvement of the skin and subcutaneous tissue were recorded in detail. This was correlated with other clinical and pathologic parameters.

Results: The incidence of skin involvement outside the nipple-areola complex was 20% (6 of 30). This was significantly related to the clinical T stage, site of the tumor, skin tethering, pathologic tumor size, and perineural infiltration. When the effects of both skin and subcutaneous tissue involvement were considered, the incidence of skin-flap involvement outside the nipple-areola complex was 23% (7 of 30). The significant parameters related to skin-flap involvement were skin tethering (75% vs. 15%; P < .05), pathologic tumor size (P < .03), and perineural infiltration (63% vs. 9%; P < .01).

Conclusions: It would be oncologically safe to perform SSM in T1 and T2 tumors, because the chance of skin involvement is small. It is safe to preserve the skin overlying the tumor if there is no skin tethering.

Key Words: Skin involvement • Invasive breast carcinoma • Skin-sparing mastectomy • Safety

This article has been cited by other articles:

				D. Cao, T. N. Tsangaris, N. Kouprina, L. S.-F. Wu, C. M. Balch, R. Vang, and P. Argani The Superficial Margin of the Skin-Sparing Mastectomy for Breast Carcinoma: Factors Predicting Involvement and Efficacy of Additional Margin Sampling Ann. Surg. Oncol., May 1, 2008; 15(5): 1330 - 1340. [Abstract] [Full Text] [PDF]

				R. Z. Torresan, C. C. dos Santos, H. Okamura, and M. Alvarenga Evaluation of Residual Glandular Tissue After Skin-Sparing Mastectomies Ann. Surg. Oncol., December 1, 2005; 12(12): 1037 - 1044. [Abstract] [Full Text] [PDF]

				M. Gutman Breast Conservation for T1-2 Breast Carcinomas Ann. Surg. Oncol., October 1, 2003; 10(8): 994 - 995. [Full Text] [PDF]

				S. E. Singletary and G. L. Robb Oncologic Safety of Skin-Sparing Mastectomy Ann. Surg. Oncol., March 1, 2003; 10(2): 95 - 97. [Full Text] [PDF]